Diabetes mellitus risk factors in rheumatoid arthritis: A systematic review and meta-analysis

Clinical and Experimental Rheumatology

Volumn 33, Issue 1, 2015, Pages 115-121

  Jiang, Ping ^a   Li, Hao ^b   Li, Xiao ^c  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diabetes mellitus; Meta analysis; Rheumatoid arthritis; Risk factor

Indexed keywords

ASIA; CASE CONTROL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPEAN; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS (TOPIC); NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; UNITED STATES; ARTHRITIS, RHEUMATOID; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; META ANALYSIS; PROGNOSIS; RISK;

ARTHRITIS, RHEUMATOID; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INCIDENCE; ODDS RATIO; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84928701957     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. LAWRENCE RC, HELMICK CG, ARNETT FC et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778-99.
2. GABRIEL SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-81.
3. GABRIEL SE, CROWSON CS, O'FALLON WM: Comorbidity in arthritis. J Rheumatol 1999; 26: 2475-9.
4. MIKULS TR, SAAG KG: Comorbidity in rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 283-303.
5. BACON PA, TOWNEND JN: Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2707-10.
6. DEL RINCON ID, WILLIAMS K, STERN MP, FREEMAN GL, ESCALANTE A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
7. MARADIT-KREMERS H, NICOLA PJ, CROWSON CS, BALLMAN KV, GABRIEL: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
8. LIAO KP, GUNNARSSON M, KäLLBERG H et al.: Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positiverheumatoid arthritis. Arthritis Rheum 2009; 60: 653-60.
9. DEL RINCóN I, WILLIAMS K, STERN MP, FREEMAN GL, O'LEARY DH, ESCALANTE: Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48: 1833-40.
10. MARADIT-KREMERS H, CROWSON CS, NICOLA PJ et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
11. GONZALEZ A, MARADIT-KREMERS H, CROWSON CS et al.: Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoidarthritis patients as in non-rheumatoid arthritis patients?. Ann Rheum Dis 2008; 67: 64-9.
12. WELLS GA, SHEA B, O'CONNELL D et al.: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute; www.ohri.ca/programs/clinical_epidemiology/oxford.asp 2011.
13. BEGG CB, MAZUMDAR M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
14. EGGER M, SMITH GD, SCHNEIDER M, MINDER C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
15. RHO YH, CHUNG CP, OESER A et al.: Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009; 61: 1580-5.
16. HAN C, ROBINSON DW Jr, HACKETT MV, PARAMORE LC, FRAEMAN KH, BALA MV: Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-72.
17. GERLI R, SHERER Y, VAUDO G et al.: Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci 2005; 1051: 281-90.
18. PIERINGER H, BRUMMAIER T, SCHMID M et al.: Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors. Semin Arthritis Rheum 2012; 42: 17-22.
19. BRADY SR, De COURTEN B, REID CM, CICUTTINI FM, de COURTEN MP, LIEW D: The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol 2009; 36: 34-40.
20. McENTEGART A, CAPELL HA, CRERAN D, RUMLEY A, WOODWARD M, LOWE GD: Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001; 40: 640-4.
21. JONSSON SW, BACKMAN C, JOHNSON O et al.: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597-602.
22. del RINCON I, HAAS RW, POGOSIAN S, ESCALANTE A: Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 425-32.
23. SIMARD JF, MITTLEMAN MA: Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol 2007; 34: 469-73.
24. DORAN MF, CROWSON CS, POND GR, O'FALLON WM, GABRIEL SE: Frequency of infection in patients with rheumatoid arthritis compared with controls: apopulation-based study. Arthritis Rheum 2002; 46: 2287-93.
25. PETERS MJ, van HALM VP, VOSKUYL AE et al.: Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease?. A prospective study. Arthritis Rheum 2009; 61:1571-9.
26. SU CC, CHEN IC, YOUNG FN, LIAN LEB: Risk of diabetes in patients with rheumatoid arthritis: a 12-year retrospective cohort study. J Rheumatol 2013; 40: 1513-8.
27. SOLOMON DH, LOVE TJ, CANNING C, SCHNEEWEISS S: Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010; 69: 2114-7.
28. SOLOMON DH, CURHAN GC, RIMM EB, CANNUSCIO CC, KARLSON EW: Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004; 50: 3444-9.
29. DUBREUIL M, RHO YH, MAN A et al.: Diabetes incidenc in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) 2014; 53: 346-52.
30. GU K, COWIE CC, HARRIS MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21: 1138-45.
31. MYLLYKANGAS-LUOSUJäRVI R, AHO K, KAUTIAINEN H, ISOMAKI H: Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995; 22: 1065-7.
32. FERRAZ-AMARO I, GONZáLEZ-JUANATEY C, LóPEZ-MEJIAS R, RIANCHO-ZARRABEITIA L, GONZáLEZ-GAY MA: Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm 2013; 2013: 710928.
33. FERRAZ-AMARO I, GARCíA-DOPICO JA, MEDINA-VEGA L, GONZáLEZ-GAY MA, DíAZ-GONZáLEZ F: Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients. Arthritis Res Ther 2013; 22: R17.
34. GONZALEZ-GAY MA, De MATIAS JM, GONZALEZ-JUANATEY C et al.: Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 83-6.
35. DESSEIN PH, STANWIX AE, JOFFE BI: Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002; 4: R5.
36. CHUNG CP, OESER A, SOLUS JF et al.: Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008; 58: 2105-12.
37. SOMERS EC, THOMAS SL, SMEETH L, HALL AJ: Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006; 17: 202-17.
38. PLENGE RM, PADYUKOV L, REMMERS EF et al.: Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-60.
39. KäLLBERG H, PADYUKOV L, PLENGE RM et al.: Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-75.
40. POPA C, NETEA MG, Van RIEL PL, der MEER JW, STALENHOEF AF: The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007; 48: 751-62.
41. AGGARWAL BB: Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB. Ann Rheum Dis 2000; 59: i6-i16.
42. BASTARD JP, MAACHI M, LAGATHU C et al.: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
43. DESSEIN PH, JOFFE BI, SINGH S: Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R634-43.
44. BURT MG, ROBERTS GW, AGUILAR-LOZA NR, AGUILAR-LOZA NR, FRITH P, STRANKS SN: Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab 2011; 96: 1789-96.
45. TRAN PD, LECLERC A, CHASTANG JF, GOLDBERG M: Regional disparities in cardiovascular risk factors in France: a five-year analysis of the GAZEL cohort. Eur J Epidermiol 1998; 14: 535-43.
46. KURIAN AK, CARDARELLI KM: Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis 2007; 17: 143-52.